Phase I study of the checkpoint kinase 1 inhibitor GDC-0575 in combination with gemcitabine in patients with refractory solid tumors
Titel:
Phase I study of the checkpoint kinase 1 inhibitor GDC-0575 in combination with gemcitabine in patients with refractory solid tumors
Auteur:
Italiano, A. Infante, J.R. Shapiro, G.I. Moore, K.N. LoRusso, P.M. Hamilton, E. Cousin, S. Toulmonde, M. Postel-Vinay, S. Tolaney, S. Blackwood, E.M. Mahrus, S. Peale, F.V. Lu, X. Moein, A. Epler, J. DuPree, K. Tagen, M. Murray, E.R. Schutzman, J.L. Lauchle, J.O. Hollebecque, A. Soria, J.-C.